/PMCUF

PMCUF Stock - Pro Medicus Limited

Q: What is the analyst price target for PMCUF?

Analyst price target information is not currently available for PMCUF.

Q: What is PMCUF's market cap?

Market capitalization information is not currently available for PMCUF.

Healthcare|Medical - Healthcare Information Services|OTC

$137.40-3.57%

$5.08 (-3.57%) • Dec 19

GoAI Score

Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.

HOLD

Medium Confidence

Momentum

Momentum Score

Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.

Sentiment

Sentiment Score

Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).

Risk Score

Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.

Price Target

Average analyst price target from the last quarter. Shows expected upside/downside from current price.

+10.0%upside

Target: $151.14

AI Analysis PreviewPremium

Real-time AI-powered market analysis

Precise entry/exit price targets

Risk assessment & position sizing

Unlock GoAI Insights for PMCUF

Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.

Buy/Sell Signals

94% win rate on Alpha signals

Deep Analysis

Institutional-grade thesis

Real-Time Alerts

SMS & push notifications

Risk Scoring

Multi-factor analysis

Free 14-day trial • No credit card required

Financial Statements

Revenue & Profitability Trend

FY2021

FY2022

FY2023

FY2024

FY2025

← Swipe to see more →

Revenue

Net Income (Profit)

Net Loss

Key Metrics

Market CapN/A

P/E RatioN/A

Beta0.75

52W High$218.25

52W Low$100.45

Avg VolumeN/A

Income Statement (Fiscal Year)

Metric	FY2025	FY2024	FY2023	FY2022	FY2021
Revenue	$212.91M	$161.50M	$124.90M	$93.46M	$67.88M
Gross Profit	$212.60M	$161.20M	$92.36M	$92.94M	$46.66M
Gross Margin	99.9%	99.8%	74.0%	99.4%	68.7%
Operating Income	$157.61M	$114.84M	$86.20M	$64.93M	$44.42M
Net Income	$115.22M	$82.79M	$60.65M	$44.44M	$30.85M
Net Margin	54.1%	51.3%	48.6%	47.6%	45.4%
EPS	$1.10	$0.79	$0.58	$0.43	$0.30

Company Overview

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Visit Website

Earnings History & Surprises

PMCUF

Beat Rate

67%

Last 12 quarters

Avg Surprise

+0.8%

EPS vs Estimate

Beats / Misses

8/4

Last 12 quarters

Latest EPS

$0.40

Q3 2025

EPS Surprise History

Q4 21

+10.9%

$0.14vs$0.13

Q2 22

+0.9%

$0.16vs$0.16

Q4 22

+5.0%

$0.18vs$0.17

Q2 23

+3.9%

$0.21vs$0.20

Q1 24

-4.7%

$0.24vs$0.25

Q3 24

+7.5%

$0.30vs$0.28

Q1 25

+0.7%

$0.31vs$0.30

Q3 25

+4.4%

$0.40vs$0.38

Beat Estimate

Missed Estimate

Quarterly EPS Details

Period	Report Date	Estimated EPS	Actual EPS	Surprise	Result
Q1 2026	Jan 18, 2026	—	—	—	—
Q3 2025	Aug 13, 2025	$0.38	$0.40	+4.4%	✓ BEAT
Q1 2025	Feb 13, 2025	$0.30	$0.31	+0.7%	✓ BEAT
Q3 2024	Aug 14, 2024	$0.28	$0.30	+7.5%	✓ BEAT
Q1 2024	Feb 15, 2024	$0.25	$0.24	-4.7%	✗ MISS
Q2 2023	Jun 30, 2023	$0.20	$0.21	+3.9%	✓ BEAT
Q4 2022	Dec 31, 2022	$0.17	$0.18	+5.0%	✓ BEAT
Q2 2022	Jun 30, 2022	$0.16	$0.16	+0.9%	✓ BEAT
Q4 2021	Dec 31, 2021	$0.13	$0.14	+10.9%	✓ BEAT
Q2 2021	Jun 30, 2021	$0.14	$0.12	-8.1%	✗ MISS
Q4 2020	Dec 31, 2020	$0.12	$0.10	-14.2%	✗ MISS
Q2 2020	Jun 30, 2020	$0.08	$0.07	-3.5%	✗ MISS
Q4 2019	Dec 31, 2019	$0.08	$0.08	+6.6%	✓ BEAT
Q2 2019	Jun 30, 2019	—	$0.07	—	—
Q4 2018	Dec 31, 2018	—	$0.07	—	—
Q2 2018	Jun 30, 2018	—	$0.05	—	—
Q4 2017	Dec 31, 2017	—	$0.02	—	—
Q2 2017	Jun 30, 2017	—	$0.03	—	—
Q4 2016	Dec 31, 2016	—	$0.03	—	—
Q2 2016	Jun 30, 2016	—	$0.02	—	—

Frequently Asked Questions about PMCUF

What is PMCUF's current stock price?

Pro Medicus Limited (PMCUF) is currently trading at $137.40 per share. The stock has moved -3.57% today.

What is the analyst price target for PMCUF?

No analyst price targets are currently available for this stock.

What sector is Pro Medicus Limited in?

Pro Medicus Limited operates in the Healthcare sector, specifically within the Medical - Healthcare Information Services industry. The company is traded on the OTC exchange.

What is PMCUF's market cap?

Pro Medicus Limited has a market capitalization of $14.35 billion, making it a large-cap company.

Does PMCUF pay dividends?

No, Pro Medicus Limited does not currently pay a dividend to shareholders.